NCT01303406 Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI) Status COMPLETED Phase PHASE3
NCT01035671 Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia Status COMPLETED Phase PHASE2
NCT01016366 Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia Status COMPLETED Phase PHASE2
NCT00905268 A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients Status COMPLETED Phase PHASE3
NCT00897221 A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia Status COMPLETED Phase PHASE2
NCT00811681 Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept Status COMPLETED Phase PHASE3
NCT00803868 Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia Status TERMINATED Phase PHASE2/PHASE3
NCT00697073 Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients Status COMPLETED Phase PHASE3
NCT00631202 Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia Status COMPLETED Phase PHASE2
NCT00537680 Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Status COMPLETED Phase PHASE3
NCT00530127 A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia Status COMPLETED Phase PHASE1/PHASE2